Chronic Low-back Pain Clinical Trial
Official title:
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3857210 for the Treatment of Chronic Low Back Pain
Verified date | July 2023 |
Source | Eli Lilly and Company |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purpose of this study is to assess whether LY3857210 is safe and efficacious in relieving chronic low back pain (CLBP). This trial is part of the chronic pain master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new treatments for chronic pain.
Status | Completed |
Enrollment | 138 |
Est. completion date | June 15, 2023 |
Est. primary completion date | June 9, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Have a visual analog scale (VAS) pain value =40 and <95 during screening. - Have a history of daily pain for at least 12 weeks based on participant report or medical history. - Have a body mass index <40 kilograms per meter squared (kg/m²) (inclusive). - Are willing to maintain a consistent regimen of any ongoing nonpharmacologic pain-relieving therapies (for example, physical therapy) and will not start any new nonpharmacologic pain-relieving therapies during study participation. - Are willing to discontinue all medications taken for chronic pain conditions for the duration of the study. - Have a history of low back pain for at least 3 months located between the 12th thoracic vertebra and the lower gluteal folds, with or without radiation. - Have a history of low back pain as classified by the Quebec Task Force Category 1 through 3. - Have stable glycemic control as indicated by a glycated hemoglobin (HbA1c) less than or equal to 10 at time of screening. - Are men, or women able to abide by reproductive and contraceptive requirements. Exclusion Criteria: - Have a seizure disorder, history of seizure (other than remote history of childhood febrile seizure), or a condition that would place the participant at increased risk of seizure, such as head injury (for example, skull fracture, cerebral contusion, concussion, or trauma resulting in prolonged unconsciousness), intracranial neoplasm or hemorrhage. - Have had a procedure within the past 6 months intended to produce permanent sensory loss in the target area of interest (for example, ablation techniques). - Have surgery planned during the study for any reason, related or not to the disease state under evaluation. - Have, in the judgment of the investigator, an acute, serious, or unstable medical condition or a history or presence of any other medical illness that would preclude study participation. - Have had cancer within 2 years of baseline, except for cutaneous basal cell or squamous cell carcinoma resolved by excision. - Have a substance use disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders (5th edition; DSM-5; American Psychiatric Association). - Have a positive human immunodeficiency virus (HIV) test result at screening. - Are, in the judgment of the investigator, actively suicidal and therefore deemed to be at significant risk for suicide. - Have an intolerance to acetaminophen or paracetamol or any of its excipients. - Have a history of alcohol, illicit drug, analgesic or narcotic use disorder within 2 years prior to screening. - Have used a therapeutic injection (botulinum toxin or corticosteroids) in the 3 months prior to starting the washout period. - Have history of or current compression fracture. - Have had a recent major trauma (within 6 months of baseline). - Are pregnant or breastfeeding. - Have known history of gastric or duodenal ulcers. - Have known history of inflammatory bowel disease (including ulcerative colitis or Crohn's disease). |
Country | Name | City | State |
---|---|---|---|
Puerto Rico | Ponce Medical School Foundation Inc. | Ponce | |
Puerto Rico | Latin Clinical Trial Center | San Juan | |
United States | FutureSearch Trials | Austin | Texas |
United States | Great Lakes Research Group, Inc. | Bay City | Michigan |
United States | Northwest Clinical Research Center | Bellevue | Washington |
United States | Boston Clinical Trials | Boston | Massachusetts |
United States | Synexus- Chandler | Chandler | Arizona |
United States | Northwestern University | Chicago | Illinois |
United States | META Medical Research Institute | Dayton | Ohio |
United States | Accel Research Sites- Clinical Research Unit | DeLand | Florida |
United States | Altoona Center For Clinical Research | Duncansville | Pennsylvania |
United States | Lillestol Research LLC | Fargo | North Dakota |
United States | CMR of Greater New Haven, LLC | Hamden | Connecticut |
United States | Rocky Mountain Clinical Research | Idaho Falls | Idaho |
United States | ActivMed Practices and Research | Methuen | Massachusetts |
United States | New Horizon Research Center | Miami | Florida |
United States | Suncoast Research Group | Miami | Florida |
United States | University of Miami Don Suffer Clinical Research Building | Miami | Florida |
United States | Renstar Medical Research | Ocala | Florida |
United States | Synexus - US | Orlando | Florida |
United States | Arizona Research Center | Phoenix | Arizona |
United States | Synexus Clinical Research US, Inc. | Pinellas Park | Florida |
United States | Rainier Clinical Research Center | Renton | Washington |
United States | Artemis Institute for Clinical Research | Riverside | California |
United States | StudyMetrix Research | Saint Peters | Missouri |
United States | Synexus Clinical Research US, Inc. | San Antonio | Texas |
United States | Artemis Institute for Clinical Research | San Diego | California |
United States | Clinvest Research LLC | Springfield | Missouri |
United States | MedVadis Research Corporation | Waltham | Massachusetts |
United States | North Georgia Clinical Research | Woodstock | Georgia |
Lead Sponsor | Collaborator |
---|---|
Eli Lilly and Company |
United States, Puerto Rico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline for Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) | Baseline, Up to Week 8 | ||
Secondary | Change from Baseline on the Roland Morris Disability Questionnaire (RMDQ) | Baseline, Up to Week 8 | ||
Secondary | Change from Baseline for Overall Improvement as Measured by Patient's Global Impression of Change | Baseline, Up to Week 12 | ||
Secondary | Change from Baseline for Worst Pain Intensity as Measured by NRS | Baseline, Up to Week 8 | ||
Secondary | Change from Baseline on the Visual Analog Scale (VAS) for Pain | Baseline, Up to Week 8 | ||
Secondary | Change from Baseline on the Sleep Scale from the Medical Outcomes Study (MOS Sleep Scale) | Baseline, Up to Week 8 | ||
Secondary | Total Amount of Rescue Medication | Baseline, Up to Week 8 | ||
Secondary | Change from Baseline on the EuroQol-5D 5 Level Questionnaire (EQ-5D-5L) | Baseline, Up to Week 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963451 -
Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
|
||
Completed |
NCT04283370 -
A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain
|
N/A | |
Completed |
NCT04824547 -
Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals
|
N/A | |
Completed |
NCT04046419 -
In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
|
||
Completed |
NCT04399772 -
COgNitive FuncTional Therapy+ for Chronic Low Back paIn
|
N/A | |
Recruiting |
NCT05780021 -
Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation
|
N/A | |
Completed |
NCT04555278 -
Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain
|
N/A | |
Completed |
NCT04530071 -
Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06347328 -
The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain
|
N/A | |
Not yet recruiting |
NCT04940715 -
Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT04683718 -
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management
|
N/A | |
Recruiting |
NCT05724160 -
Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT06030128 -
Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults
|
N/A | |
Recruiting |
NCT05846087 -
Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia
|
N/A | |
Active, not recruiting |
NCT05396014 -
The BEST Trial: Biomarkers for Evaluating Spine Treatments
|
Phase 4 | |
Active, not recruiting |
NCT06140862 -
Ankle Spine Syndrome "RAFFET Syndrome II
|
N/A | |
Completed |
NCT05512338 -
Motivation and Adherence to Exercise Recommendations
|
N/A | |
Recruiting |
NCT05021146 -
Essential Oil for Chronic Low Back Pain
|
N/A | |
Completed |
NCT05690178 -
Deep Tissue Massage in Office Workers With Chronic Low Back Pain
|
N/A | |
Completed |
NCT05120921 -
Osteopathic Single CAse Research for Patients With Chronic Low Back Pain
|
N/A |